People · Operator
Named in public records as an officer, director or promoter · active 2016–2022 · Defense, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CITADEL DEFENSE Co | — | Defense | Series A | $13.8M | $334.6M | 2016 |
| Direct Biologics, LLC | — | Biotechnology | Series A | $11.6M | $140.2M | 2022 |
Gordon Feller at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gordon Feller on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Adams | 1 | 7 |
| John Vrionis | 1 | 5 |
| Matthew Rogers | 1 | 4 |
| Daniel Magy | 1 | 4 |
| James Waring | 1 | 2 |
| John Joseph Vacalis | 1 | 1 |
| Jeffrey Joseph Mims | 1 | 1 |
| Joseph Makol | 1 | 1 |
| Emil Joseph Schmidt IV | 1 | 1 |
| Timothy Joseph Moseley | 1 | 1 |
| Aline M. Betancourt | 1 | 1 |
| Amy Joseph Lightner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.